Other

Sanofi to buy US biotech firm Amunix for $1 bn

French pharma giant Sanofi said Tuesday it had signed a billion-dollar deal to buy US-based biotech firm Amunix, which develops cancer treatments that enlist the body's immune system.

Inflammatory disorders

A more targeted therapy to treat inflammatory bowel disease

Biomedical scientists at the University of California, Riverside, propose a way for drugs to be more effective against inflammatory bowel disease, or IBD, in which the intestine undergoes inflammation.

Oncology & Cancer

Blood-based tests to detect and monitor lung cancer

To diagnose lung cancer, tumor tissue is collected from a patient and checked for signs of cancer. However, this is not always possible due to tumor location, and can be painful for the patient. For his Ph.D. research, Remco ...

Medical research

Parallels in human, dog oral tumors could speed new therapies

Recent Cornell research compared the genetic expression profiles of a nonlethal canine tumor and the rare, devastating human oral tumor it resembles, laying the groundwork for potential translational medicine down the road.

Oncology & Cancer

Tissue physics plays a key role in tumor growth

Cancer is a difficult disease to treat and to study, and can be caused by a range of genetic mutations. For instance, the mutated RAS gene causes a loss of structure in so-called epithelial tissue, a tissue type that lines ...

Oncology & Cancer

Optimizing preoperative radiation therapy in high-risk sarcoma

In a phase 2 single-institution study, UCLA Jonsson Comprehensive Cancer Center researchers found that dose-equivalent preoperative radiation therapy for extremity/trunk soft tissue sarcoma delivered in five days rather than ...

page 10 from 40